Chester County News and Community Website
NEWARK, DE — Wilmington PharmaTech announced it will invest $50 million to expand its Delaware campus, increasing manufacturing capacity to meet demand for U.S.-based production of pharmaceutical ingredients.
Wilmington PharmaTech Plans $50 Million Delaware Expansion Read More NEWARK, DE — Wilmington PharmaTech said it has appointed Mike Shearer as chief commercial officer, tasking the longtime pharmaceutical services executive with driving growth, expanding client relationships, and strengthening the …
Wilmington PharmaTech Names Veteran Exec to Lead Commercial Push Read More NEWARK, DE — Wilmington PharmaTech (WPT) has appointed Kent Payne, Ph.D., as Managing Director and Board Member, marking a key leadership addition following a recent investment from Curewell Capital, a …
Wilmington PharmaTech Names Kent Payne Managing Director to Drive U.S. Expansion Read More
NEWARK, DE — Wilmington PharmaTech (WPT), a U.S.-based manufacturer of small molecule active pharmaceutical ingredients (API), announced that Los Angeles–based private equity firm Curewell Capital has made a majority investment …
Curewell Capital Takes Majority Stake in Wilmington PharmaTech to Drive Expansion Read More